1 min read
Biopharma Thought Leadership Blog
Explore blog posts from our AGC Biologics scientific experts sharing insights and innovations on drug development and manufacturing strategies.
Mammalian & mAbs (2)

2 min read
MAb-solutely! New Alternative to Costly Resin Helps Antibodies Reach Clinical Milestones

2 min read
Enhancing Collaboration and Transparency in Commercial Biologics Manufacturing

1 min read
Study: Single-Use Protein A Membrane Capture Technology Offers Cost Savings and Innovation for mAb Development

1 min read
Key Considerations When Outsourcing Large-Scale Manufacturing

3 min read
Do Monoclonal Antibodies offer a Roadmap to Scale-Up for Viral Vector Production?


